Evaluating the Progression of Large Language Model Capabilities for Small-Molecule Drug Design

This research evaluates the evolving capabilities of large language models (LLMs) in the complex domain of small-molecule drug design. It assesses their performance in generating, optimizing, and predicting properties of novel drug candidates, providing critical insights into their utility and progression for pharmaceutical research and development.